Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disturbance; Vision, Loss”

110 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 110 results

Not applicableStudy completedNCT06176625
What this trial is testing

Sight and Hearing Investigation Into Effects on Delirium

Who this might be right for
Hearing LossHearing Loss, Age-RelatedHearing Disability+14 more
Johns Hopkins University 1,543
Testing effectiveness (Phase 2)Study completedNCT01838655
What this trial is testing

Nitisinone for Type 1B Oculocutaneous Albinism

Who this might be right for
AlbinismVision Loss
National Eye Institute (NEI) 5
Post-approval studies (Phase 4)Study completedNCT04679935
What this trial is testing

Efficacy and Safety of Two Different Brolucizumab 6 mg Dosing Regimens in Neovascular Age-related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Novartis Pharmaceuticals 52
Large-scale testing (Phase 3)Study completedNCT02652767
What this trial is testing

Efficacy Study of GS010 for the Treatment of Vision Loss up to 6 Months From Onset in LHON Due to the ND4 Mutation

Who this might be right for
Optic, Atrophy, Hereditary, Leber
GenSight Biologics 39
Post-approval studies (Phase 4)Study completedNCT05269966
What this trial is testing

Study to Evaluate the Safety and Effectiveness of Intravitreal Injections (IVI) of Brolucizumab in Patients With Neovascular Age-related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)
Novartis Pharmaceuticals 105
Not applicableStudy completedNCT05098236
What this trial is testing

Effect of Visual Retraining on Visual Loss Following Visual Cortical Damage

Who this might be right for
Vision Loss PartialHemianopiaHemianopia Homonymous+2 more
University of Rochester 280
Not applicableLooking for participantsNCT07015034
What this trial is testing

Developing and Testing a Model to Identify Preventive Vision Loss Among Older Patients in General Practice

Who this might be right for
Vision Impairment and BlindnessGlaucomaAge-Related Macular Degeneration+2 more
University of Copenhagen 460
Early research (Phase 1)Study completedNCT00056199
What this trial is testing

EYE001 to Treat Retinal Tumors in Patients With Von Hippel-Lindau Syndrome

Who this might be right for
Hippel-Lindau Disease
National Eye Institute (NEI) 5
Not applicableStudy completedNCT03626207
What this trial is testing

Development of Visual Function Evaluation Method (2)

Who this might be right for
Retinitis Pigmentosa
Astellas Pharma Inc 8
Not applicableStudy completedNCT00829036
What this trial is testing

Wayfinding Information Access System for People With Vision Loss

Who this might be right for
Blindness
US Department of Veterans Affairs 24
Not applicableStudy completedNCT03653715
What this trial is testing

Bifocal Contact Lens Study for Adults With Age-Related Near Vision Loss

Who this might be right for
Presbyopia
Clerio Vision, Inc. 30
Large-scale testing (Phase 3)Study completedNCT05520177
What this trial is testing

A Phase III Study for 601 Versus Ranibizumab in Patients With Vision Loss

Who this might be right for
Branch Retinal Vein Occlusion
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 351
Not applicableLooking for participantsNCT07073521
What this trial is testing

Developing Evidence-Based Cognitive Approaches to Improve Adjustment to Vision Loss

Who this might be right for
Depression, AnxietyVisual ImpairmentAdjustment+5 more
The Chicago Lighthouse 45
Not applicableWithdrawnNCT00926913
What this trial is testing

Investigating Optical and Neural Causes of Vision Loss

Who this might be right for
Macular Degeneration
US Department of Veterans Affairs
Early research (Phase 1)Study completedNCT01604356
What this trial is testing

Acupuncture for the Treatment of Vision Loss Due to Retinitis Pigmentosa

Who this might be right for
Retinitis Pigmentosa
Johns Hopkins University 19
Large-scale testing (Phase 3)Study completedNCT01922102
What this trial is testing

Efficacy and Safety of Ranibizumab 0.5 vs Verteporfin PDT in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia

Who this might be right for
Visual Impairment Due to Choroidal Neovascularization (CNV) Secondary to Pathologic Myopia (PM)
Novartis Pharmaceuticals 457
Not applicableStudy completedNCT01363570
What this trial is testing

Evaluation of Wet Age-Related Macular Degeneration (AMD) Genetic Profile Interactions With Ranibizumab Treatment Outcomes

Who this might be right for
Age Related Macular Degeneration
McMaster University 70
Not applicableEnded earlyNCT01415453
What this trial is testing

Evoked Retinal Response

Who this might be right for
Retinitis Pigmentosa
Columbia University 1
Post-approval studies (Phase 4)Study completedNCT01775124
What this trial is testing

Efficacy and Safety of Ranibizumab 0.5 mg Administered as Two Alternative Dosing Regimens in Chinese Patients With nAMD (Age Related Macular Degeneration)

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 332
Post-approval studies (Phase 4)Study completedNCT04774926
What this trial is testing

Study of Innovative Multimodal Imaging Biomarkers to Predict Anatomical Outcome in Naive Patients With wAMD Treated With Brolucizumab.

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 122
Load More Results